Related Experiment Video
Updated: Jul 24, 2025

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
The landscape of cancer rewired GPCR signaling axes
Chakit Arora1, Marin Matic1, Pierluigi DiChiaro2
1Laboratorio di Biologia Bio@SNS, Scuola Normale Superiore, Piazza dei Cavalieri 7, 56126, Pisa, Italy.
Abstract:
We explored the dysregulation of GPCR ligand signaling systems in cancer transcriptomics datasets to uncover new therapeutics opportunities in oncology. We derived an interaction network of receptors with ligands and their biosynthetic enzymes, which revealed that multiple GPCRs are differentially regulated together with their upstream partners across cancer subtypes. We showed that biosynthetic pathway enrichment from enzyme expression recapitulated pathway activity signatures from metabolomics datasets, providing valuable surrogate information for GPCRs responding to organic ligands. We found that several GPCRs signaling components were significantly associated with patient survival in a cancer type-specific fashion. The expression of both receptor-ligand (or enzymes) partners improved patient stratification, suggesting a synergistic role for the activation of GPCR networks in modulating cancer phenotypes. Remarkably, we identified many such axes across several cancer molecular subtypes, including many pairs involving receptor-biosynthetic enzymes for neurotransmitters. We found that GPCRs from these actionable axes, including e.g., muscarinic, adenosine, 5-hydroxytryptamine and chemokine receptors, are the targets of multiple drugs displaying anti-growth effects in large-scale, cancer cell drug screens. We have made the results generated in this study freely available through a webapp (gpcrcanceraxes.bioinfolab.sns.it).
Insights
This study reveals how G protein-coupled receptor (GPCR) signaling networks are altered in cancer. Targeting these GPCR axes offers new therapeutic strategies for oncology.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
- Dysregulation of GPCR signaling pathways is implicated in various cancer types, highlighting their potential as therapeutic targets.
Approach:
- Analysis of cancer transcriptomics datasets to construct GPCR-ligand-enzyme interaction networks.
- Utilized enzyme expression to infer pathway activity and GPCR ligand responses.
- Investigated associations between GPCR signaling components and patient survival across cancer subtypes.
Key Points:
- GPCRs and their upstream partners are differentially regulated across cancer subtypes.
- GPCR network activity is linked to patient survival, with combined receptor-ligand/enzyme expression improving stratification.
- Identified specific GPCR axes, including those involving neurotransmitter biosynthetic enzymes, as actionable targets.
Conclusions:
- GPCR signaling networks play a synergistic role in modulating cancer phenotypes.
- GPCRs targeted by existing drugs show anti-growth effects in cancer cell screens.
- The findings provide a web-accessible resource (gpcrcanceraxes.bioinfolab.sns.it) for exploring GPCR-based cancer therapeutics.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity
MAPK Signaling Cascades

